Prognostic performance of the two-step clinical care pathway in metabolic dysfunction-associated steatotic liver disease
Terry Cheuk‐Fung Yip(Chinese University of Hong Kong), Vincent Wai‐Sun Wong(Chinese University of Hong Kong), Amon Asgharpour, George Boon‐Bee Goh(Singapore General Hospital), Laurent Castéra(Inserm), Emmanuel Tsochatzis(Royal Free London NHS Foundation Trust), Kevin Teh(Singapore General Hospital), Masato Yoneda(Yokohama City University), Ming‐Hua Zheng(Wenzhou Medical University), Clémence M. Canivet(Université d'Angers), Manuel Romero‐Gómez(Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas), José Luís Calleja(Hospital Universitario Puerta de Hierro Majadahonda), Michelle Lai(Beth Israel Deaconess Medical Center), Elisabetta Bugianesi(University of Turin), Philip N. Newsome(University of Birmingham), Victor de Lédinghen(Université de Bordeaux), Ying Shang(Karolinska Institutet), Elba Llop(Hospital Universitario Puerta de Hierro Majadahonda), Angelo Armandi(Johannes Gutenberg University Mainz), Hannes Hagström(Karolinska University Hospital), Rocío Gallego‐Durán(Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas), Jérôme Boursier(Michael E. DeBakey VA Medical Center), Carmen Lara‐Romero(Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas), Salvatore Petta(Department of Health), Céline Fournier‐Poizat, Arun J. Sanyal(Virginia Commonwealth University), Grazia Pennisi(University of Palermo), Wah‐Kheong Chan(University of Malaya), Grace Lai‐Hung Wong(Chinese University of Hong Kong), Marc de Saint-Loup(Université d'Angers), Seung Up Kim(Pusan National University), Hye Won Lee(Korea National Institute of Health), Mandy Sau-Wai Chan, Jian‐Gao Fan(XinHua Hospital), Huapeng Lin(Chinese University of Hong Kong), Atsushi Nakajima(Yokohama City University), Sara Mahgoub(University Hospitals Birmingham NHS Foundation Trust), Wen‐Yue Liu(Wenzhou Medical University)
Cited by 35
Related Papers
The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases
|Hepatology|2017|7.2k
Pioglitazone, Vitamin E, or Placebo for Nonalcoholic Steatohepatitis
|New England Journal of Medicine|2010|3.3k
A multisociety Delphi consensus statement on new fatty liver disease nomenclature
|Hepatology|2023|2.9k
A multisociety Delphi consensus statement on new fatty liver disease nomenclature
|Journal of Hepatology|2023|2.7k